biostudies-literatureUnknown10Cho EMinistry of SMEs and Startups<h4>Background</h4>Obesity is a socioeconomic problem, and visceral obesity, in particular, is related to cardiovascular diseases or metabolic syndrome. Fermented grains and various microorganisms are known to help with anti-obesity effects and weight management. Studies on the relationship between <i>Bacillus coagulans</i> and anti-obesity effects are not well known, and studies on the application of fermented grains and microorganisms to the human body are also insufficient.<h4>Objectives</h4>This study aimed to evaluate the efficacy of Curezyme-LAC, an ingredient mixed with six-grain types fermented by <i>B. coagulans</i>, in reducing fat mass in adults with obesity.<h4>Methods</h4>In this randomized double-blinded placebo-controlled study, 100 participants [aged 40-65 years; body mass Frontiers in nutrition1148512https://www.ebi.ac.uk/biostudies/studies/S-EPMC10149940biostudies-literatureEfficacy of fermented grain using <i>Bacillus coagulans</i> in reducing visceral fat among people with obesity: a randomized controlled trial.PMC10149940Lee JSKim SGil SKim JYKim HYoon YCShin YCCho BCho EfalseEfficacy of fermented grain using <i>Bacillus coagulans</i> in reducing visceral fat among people with obesity: a randomized controlled trial.<h4>Background</h4>Obesity is a socioeconomic problem, and visceral obesity, in particular, is related to cardiovascular diseases or metabolic syndrome. Fermented grains and various microorganisms are known to help with anti-obesity effects and weight management. Studies on the relationship between <i>Bacillus coagulans</i> and anti-obesity effects are not well known, and studies on the application of fermented grains and microorganisms to the human body are also insufficient.<h4>Objectives</h4>This study aimed to evaluate the efficacy of Curezyme-LAC, an ingredient mixed with six-grain types fermented by <i>B. coagulans</i>, in reducing fat mass in adults with obesity.<h4>Methods</h4>In this randomized double-blinded placebo-controlled study, 100 participants [aged 40-65 years; body mass 2023-01-01T00:00:00Z20232026-04-15T03:10:54.798Z2024-12-04T11:50:07.468ZS-EPMC101499403713944810.3389/fnut.2023.1148512